戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 on in the Mycobacterium tuberculosis Ser/Thr kinome.
2 ry RGCs and used it to screen the full mouse kinome.
3 ein kinase as a representative of the entire kinome.
4 ase (AMPK), which defines this branch of the kinome.
5 ti-malarial drug targets within the parasite kinome.
6 covering >80% of the human catalytic protein kinome.
7 nsive loss-of-function screen of the protein kinome.
8 racteristic of kinases in this region of the kinome.
9 at highlights areas of unmet need within the kinome.
10 esenting >50% of the predicted human protein kinome.
11 on of how inhibitors interact with the human kinome.
12 iminary in silico analysis of the sea urchin kinome.
13 NA interference (RNAi) vectors targeting the kinome.
14 understanding of the historically untargeted kinome.
15 d coverage ( approximately 80%) of the human kinome.
16 ize and activate more than half of the human kinome.
17 the appearance of kinases de novo within the kinome.
18 ificantly influence selectivity in the human kinome.
19 fy quantotypic peptides for 21% of the human kinome.
20 protein kinases, is closer to the Drosophila kinome (239) than the human kinome (518) with respect to
21 of kinase activity assays spanning the human kinome (243 kinases).
22 o the Drosophila kinome (239) than the human kinome (518) with respect to total kinase number.
23 in a regulatory manner, we performed a whole kinome (779 kinases) siRNA screen for positive or negati
24                         When we compared the kinome across the six cell lines, representative of diff
25 uantitative proteomics approach, we assessed kinome activity in response to MEK inhibition in triple-
26                       We applied this unique kinome-activity profiling strategy in a variety of cellu
27 edback between MCL cells and TME, leading to kinome adaptive reprogramming, bypassing the effect of i
28                        Toxoplasma has in its kinome among the highest percentage of pseudokinases amo
29                                            A kinome analysis combined with chemical and genetic appro
30                                              Kinome analysis data reflected this altered host cell ph
31 ling pathway intermediates identified in our kinome analysis inhibited viral replication in vitro and
32                                     A global kinome analysis of CDK4-deficient mice following insulin
33  signaling intermediates identified from our kinome analysis provided partial protection in a lethal
34                                              Kinome analysis revealed multiple PtpA-dependent changes
35 phosphorylation events, we employed temporal kinome analysis to investigate the functional responses
36                         We employed temporal kinome analysis to investigate the relative early, inter
37 ng pathway intermediates identified from our kinome analysis, also inhibited EBOV replication.
38     The large number of pseudokinases in the kinome and an increasing appreciation that they have cri
39                   Kinannote produces a draft kinome and comparative analyses for a predicted proteome
40 also occur in ALL, we sequenced the tyrosine kinome and downstream signaling genes in 45 high-risk pe
41 notype 1b replicon cell line (Luc-1b) with a kinome and druggable collection of 20,779 siRNAs.
42 isms underplaying the regulation between the kinome and EMT require further elucidation to define tar
43 mily of Ser-Thr protein kinases in the human kinome and have diverse roles in broad physiological fun
44 strains representing the non-essential yeast kinome and identified a single kinase gene, ELM1, as nec
45 ng RNA (siRNA) screen targeting the cellular kinome and identified Tousled-like kinases (TLKs) as cel
46 g 734 kinase genes covering the entire mouse kinome and individually examined their effects on iPSC g
47                                 The tyrosine kinome and phosphatome harbor oncogenes and tumor suppre
48 ng a loss-of-function screening of the human kinome and phosphatome to identify genes suppressing tum
49 in vivo RNAi screen targeting the Drosophila kinome and phosphatome, we identify 11 kinases and phosp
50 Here we present a method to study the global kinome and phosphoproteome in tandem in a model photosyn
51 xamined nucleic acid variations in the human kinome and several known cancer-related genes in breast
52 oxoplasma and Plasmodium of their respective kinomes and phosphoproteomes.
53  Scaffold coverage varied greatly across the kinome, and many scaffolds representing compounds with d
54 ative mass spectrometry to profile proteome, kinome, and phosphoproteome changes in an established mo
55 number of cancer-associated mutations in the kinome, and the progress in developing specific small-mo
56 tegrated into inhibitor discovery across the kinome, and we outline some immediate consequences for s
57  challenges and outlook for drugging the PI3 kinome are discussed in the more general context of the
58                                          The kinomes are stored in a relational database and are acce
59                                              Kinome array analysis demonstrated that CD28(+)CD151(+)
60                                 Further, the kinome array analysis identified changes in the activati
61 d by Western blotting, flow cytometry, and a kinome array protocol.
62 on that is highly conserved within the human kinome as demonstrated by our sequence analysis and stru
63 igand binding modes for the human structural kinome at scale (208 kinases, 1777 unique ligands, and t
64 selectivity over group I PAKs, and the broad kinome, based on unique flexibility of this lipophilic p
65 demonstrate that Cdc37 has a general role in kinome biogenesis.
66 ed by wrapping differences across its target kinome can selectively direct its impact toward a specif
67 han 500 protein kinases comprising the human kinome catalyze hundreds of thousands of phosphorylation
68 uantitative phosphoproteomics with mammalian kinome cDNA library screen.
69 ed kinase inhibition can induce compensatory kinome changes, rendering single therapeutic agents inef
70                         Thus, the sea urchin kinome combines the simplicity of a non-duplicated genom
71                            The human protein kinome comprises 535 proteins that, with the exception o
72                                    The human kinome comprises over 800 individual kinases.
73         The results show that the sea urchin kinome, consisting of 353 protein kinases, is closer to
74                                          The kinome consists of 518 kinases, and every active protein
75 everal classes of signaling molecules, their kinomes contain a large and diverse set of protein kinas
76 uggests that other pseudokinases (10% of the kinome) could also be catalytically active.
77 inase expression and activation have limited kinome coverage.
78 -protein interaction networks generated from kinome data could further be used to guide targeted gene
79  analysis and functional network analysis of kinome data revealed that transforming growth factor (TG
80    Upregulation of TGF-beta signaling in the kinome data sets correlated with the upregulation of TGF
81                                Mining of the kinome database revealed that a subset of some 46 kinase
82 he complement of Drosophila protein kinases (kinome) for cell cycle functions after gene silencing by
83 is of all known sequences in the A. thaliana kinome found that alphaC helix disorder may be a common
84    Approximately one-third of the Drosophila kinome has been ascribed some cell-cycle function.
85 ted Tyr and Ser/Thr kinases, over 85% of the kinome has been identified to be dysregulated in at leas
86             Structural coverage of the human kinome has been steadily increasing over time.
87         The strategy of 'drugging the cancer kinome' has led to the successful development and regula
88 e kinase complement of the human genome, the kinome, has provided an excellent starting point for und
89 essential functions for the malaria parasite kinome have been reported, the roles of most protein pho
90 Recent analysis of the Plasmodium falciparum kinome identified several kinases that are entirely uniq
91 ification and comparison with model organism kinomes identified orthologous groups and highlighted ex
92            A recent analysis of the tyrosine kinome in colorectal cancer identified c-fes as one of o
93 ly the arsenite-induced alteration of global kinome in human cells.
94  cell growth, transcriptome, metabolome, and kinome in response to paracrine signals emerging from ir
95                     Analysis of the platelet kinome in the context of the kinase phylogenetic backgro
96  constituting an extensive and diverse sugar kinome in the thermophilic bacterium Thermotoga maritima
97 e protein kinases ( approximately 50% of the kinome) in a cdc37 mutant strain showed that 51 had decr
98 erved only in 8 of the >90 PTKs in the human kinome, including 3 of the 10 Src family kinases and all
99  WNK kinases are unique members of the human kinome, intimately involved in maintaining electrolyte b
100 s (approximately 70% of mammalian structural kinome) into accurate and specific models of their type-
101                Thus, about half of the human kinome is currently covered with active small molecules.
102 roducing hypotheses that can explain how the kinome is involved in the maintenance of different cellu
103 risingly similar to humans, since the urchin kinome is missing only 4 of 186 human subfamilies, while
104    The distribution of inhibitors across the kinome is uneven.
105 tivity of Cdc37 could dramatically alter the kinome, leading to profound changes in the tau phosphory
106 e delivery and/or expression by performing a kinome-level screen in which, we identified small-molecu
107            We constructed a SILAC-compatible kinome library for scheduled multiple-reaction monitorin
108 er cells with a lentivirus short hairpin RNA kinome library.
109 itative assessment of perturbation in global kinome may provide crucial knowledge for elucidating the
110 quantitative analysis of the perturbation of kinome of GM00637 human skin fibroblast cells induced by
111 omprehensively the alterations of the global kinome of HEK293T human embryonic kidney cells upon trea
112 his study provides a global insight into the kinome of S. haematobium and should assist the repurposi
113         In this context, we defined here the kinome of S. haematobium using a refined bioinformatic p
114                                          The kinome of the human malaria parasite Plasmodium falcipar
115 ned the full protein kinase (PK) complement (kinome) of mouse.
116 se in coverage of the enriched Chlamydomonas kinome over coverage found with no enrichment.
117                                  For larger "kinome" panels, the partition index allows assessment of
118 king of altered kinases generated from these kinome profile data predicted PIM-1 kinase as a key swit
119                                              Kinome profiling and cellular studies demonstrate that,
120  latent HIV-1 integration event and position kinome profiling as a research tool to reveal novel mole
121 hanism of sorafenib activity through in situ kinome profiling identified the mitogen-activated protei
122 -throughput, SILAC-compatible, and MRM-based kinome profiling method and demonstrated that the method
123                       Together, our targeted kinome profiling method offers a powerful resource for e
124                                 The improved kinome profiling methods described here represent an eff
125                                              Kinome profiling revealed 5-IT to be a potent and select
126                                    Moreover, kinome profiling uncovers disruption of multiple signal
127                                              Kinome profiling versus more than 300 kinases in vitro a
128         The KAYAK (Kinase ActivitY Assay for Kinome profiling) assay measures the phosphorylation rat
129 ellular phosphorylation events (often called kinome profiling).
130 dvanced analysis tools are yet available for kinome profiling.
131  as compared to classical analysis tools for kinome profiling.
132                 Unbiased transcriptional and kinome reprogramming analyses from selected treatment ti
133 but lost its direct antitumor effects due to kinome reprogramming, which resulted in suppression of p
134 ion of proteasomal c-Myc degradation blocked kinome reprogramming.
135  relative early, intermediate, and late host kinome responses to EBOV infection in human hepatocytes.
136    The average sensitivity and precision for kinome retrieval from the test species are 94.4 and 96.8
137 nalysis of the mutation catalog in the human kinome revealed the presence of cancer-associated mutati
138 c targets, we performed an unbiased tyrosine kinome RNA interference screen in primary cell cultures
139                                 From a human kinome RNAi screen, we have identified Lats2 kinase as a
140 therapeutic efficacy of RITs, we conducted a kinome RNAi sensitization screen, which identified disco
141 m publicly available inhibitors of the human kinome, scaffolds and cyclic skeletons were systematical
142 ith protein tyrosine kinases is conducted on kinome scale by using evolutionary analysis and fingerpr
143                                      Further kinome-scale siRNA screening demonstrated that SRC MEK5
144                                      Using a kinome screen and a systems biology approach, we identif
145                                An RNAi-based kinome screen revealed that LYN is required for growth o
146 e of intracellular signaling, we performed a kinome screen using a label-free assay and found that me
147                 Here using an unbiased siRNA kinome screen, we identify and validate casein kinase 1a
148 creen the P. berghei kinome, using published kinome screens for comparison.
149                                     In Ambit kinome screens, cell growth inhibition studies, and surr
150                  Furthermore, we developed a kinome selective irreversible inhibitor 45a with an IC50
151  emphasize the outstanding properties of the kinome-selective JAK inhibitor CP-690550, as well as the
152 21i (AC081), two structurally novel, potent, kinome-selective pan-Aurora inhibitors.
153            Development of a series of highly kinome-selective spleen tyrosine kinase (Syk) inhibitors
154 ora A inhibitor (IC50 = 2 nM) with very high kinome selectivity for Aurora kinases.
155 tent LRRK2 inhibitors, focusing on improving kinome selectivity using a surrogate crystallography app
156 razines, to a potent example with reasonable kinome selectivity, including selectivity for JAK3 versu
157 f kinase therapeutics with high efficacy and kinome selectivity, thus avoiding problems observed with
158                   Data from this first siRNA-kinome sensitizer screen suggests that inhibiting WEE1 i
159                                       Cancer kinome sequencing studies have identified several protei
160                    Assessment of the phospho-kinome showed decreased phosphorylation of pathways invo
161 B4 mutations can induce broad changes in the kinome signature of lung cancer cells.
162                       Screening libraries of kinome siRNA and small molecules, we defined PLK1 as an
163      In accordance with the chemical screen, kinome small interfering RNA high throughput screens ide
164 ucture-binding relationships in the tyrosine kinome space in which evolutionary analysis of the kinas
165 mined by their phylogenetic proximity in the kinome space or differences in the interactions with the
166 e interrogation of all elements of the human kinome supporting EGF-dependent signaling.
167  architecture of the M. tuberculosis Ser/Thr kinome that could enable horizontal signal spreading.
168  focusing on mutations in the kinase genome (kinome) that lead to tumorigenesis.
169 ein kinase A is the prototype for the entire kinome, these findings may serve as a paradigm for descr
170 se of high-throughput screening of the yeast kinome to facilitate the major task of identifying human
171 y, we performed an siRNA-based screen of the kinome to identify genetic regulators of PGRN levels in
172 ved models are evenly distributed across the kinome tree, allowing reliable profiling prediction for
173 rotein and lipid kinases, leaving 70% of the kinome untapped.
174  kinase complement of the human genome (the "kinome") using public and proprietary genomic, complemen
175 of this resource, we rescreen the P. berghei kinome, using published kinome screens for comparison.
176                   Relying on extensive human kinome vetting, we show that (R)-3 is the most potent an
177 NAi) screen targeting 542 genes of the human kinome was used to discover regulators of RNAi.
178     Through a functional screen of the human kinome, we found that mammalian sterile 20-like kinase 1
179                Through RNAi screening of the kinome, we have identified Misshapen (Msn) and the mamma
180 , by conducting a shRNA screen targeting the kinome, we identified PIM1, a non-essential serine-threo
181       Through a systematic evaluation of the kinome, we identified Pro455 and Asn457 in the Syk ATP b
182 ove our understanding of HIF-1 regulation by kinome, we screened a kinase-specific small interference
183 ymatic assays, chemical proteomic profiling, kinome-wide activity surveys and MTH1 co-crystal structu
184                      Finally, we present the kinome-wide analysis of mRNA expression dynamics induced
185                   Our calculations predict a kinome-wide conformational plasticity, and indicate the
186 e presented approach opens possibilities for kinome-wide discovery of specific molecules targeting in
187 l of multiple endocrine neoplasia type 2 and kinome-wide drug profiling, here we identify that AD57 r
188 hese agents, we have undertaken a systematic kinome-wide effort to profile their selectivity and pote
189      Using a chemogenomics approach marrying kinome-wide inhibitory profiles of a compound library wi
190                        We further reported a kinome-wide landscape of pharmacogenomic interactions by
191 computational oncoproteomics approach, named kinome-wide network module for cancer pharmacogenomics (
192 from an in vivo tumorigenesis screen using a kinome-wide open reading frames (ORFs) library.
193                           In turn, through a kinome-wide phosphoproteomic and MS study, we demonstrat
194 tudies establish the feasibility of tyrosine kinome-wide phosphorylation profiling and point to SRC a
195          Combining kinase-focused chemistry, kinome-wide profiling and Drosophila genetics provides a
196 e, we desired to increase the throughput for kinome-wide profiling.
197                                            A kinome-wide reverse genetics strategy identified 36 para
198 mbine global phospho-proteomic analysis with kinome-wide reverse genetics to assess the importance of
199 l components of this pathway, we performed a kinome-wide RNA interference (RNAi) screen in Drosophila
200                                            A kinome-wide RNA interference screen was used to identify
201  to gammaherpesvirus through two independent kinome-wide RNA interference screens.
202                                     A recent kinome-wide RNAi screen with 176 individual bloodstream
203                               Using unbiased kinome-wide RNAi screening followed by thorough validati
204                            Here, we report a kinome-wide RNAi-based analysis to identify kinases that
205                                          The kinome-wide screen demonstrated a strong inverse correla
206 ical properties and notable selectivity in a kinome-wide screen.
207                                              Kinome-wide screening would have the advantage of provid
208                                        These kinome-wide screens, performed within a day on a small c
209 s illustrate for the first time the use of a kinome-wide selective radioactive chemical probe for end
210                                              Kinome-wide selectivity profiling of the library resulte
211                                              Kinome-wide sequence mining revealed rare presentation o
212                               We performed a kinome-wide siRNA screen and identified 70 kinases alter
213                        Here, a comprehensive kinome-wide siRNA screen in a human HeLa cell-based mode
214                                            A kinome-wide siRNA screen showed that the insulin recepto
215                     In this study, we used a kinome-wide siRNA screen to identify kinases that, when
216                                            A kinome-wide siRNA screen using a library targeting 720 k
217  as were other protein kinases identified by kinome-wide siRNA screening and a genetic gain-of-functi
218 d a functional kinomics approach including a kinome-wide siRNA-phosphoproteomic screen, a high-conten
219                     We therefore conducted a kinome-wide small interfering RNA (siRNA) lethality stud
220 tly label a broad swath of the intracellular kinome with high efficiency.
221 cted a siRNA screening targeted to the human kinome with the aim of discovering new EMT effectors.
222 selection of kinases from each branch of the kinome, with and without known substrates, highlighting

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top